News
-
-
PRESS RELEASE
Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Protagonist Therapeutics announces selection of PN-881, an oral peptide interleukin-17 antagonist, as a development candidate for immune-mediated skin diseases. IND enabling studies ongoing with Phase I expected in Q425 -
-
PRESS RELEASE
Inventiva publie ses informations financières du 3ème trimestre 2024¹
Inventiva publie ses informations financi\u00e8res du 3\u00e8me trimestre 2024 avec tr\u00e9sorerie de 13,9 millions d'euros, chiffre d'affaires de 1,3 million sur neuf mois, \u00e9mission de certificats de redevance, pr\u00e9visions de financement jusqu'en 2025 -
PRESS RELEASE
Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Seventy Ninth Resources Ltd completes successful reconnaissance trip to McKellar copper-zinc project and Enable gold project in Ontario, Canada. Historic high-grade results revealed -
-
PRESS RELEASE
For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
For Us TV, owned by Blockchain Loyalty Corp., opens submissions for BIPOC filmmakers to share diverse stories on major streaming platforms. Producers collaborate on inclusive projects promoting underrepresented voices -
-
-
